Skip to main content
Professional Technical IVT

inclusion body myositis

Progressive inflammatory myopathy characterized by weakness of distal and proximal muscles with distinctive pathological inclusions.

Full Definition

Inclusion body myositis (IBM) is the most common inflammatory myopathy in patients over 50 years, characterized by progressive weakness affecting both proximal and distal muscles, particularly finger flexors and knee extensors. The condition presents with asymmetric muscle weakness, often involving swallowing difficulties and falls. Pathologically, muscle biopsy reveals inflammatory infiltrates, rimmed vacuoles, and characteristic protein inclusions containing amyloid and tau. Unlike other inflammatory myopathies, IBM typically responds poorly to immunosuppressive therapy. Diagnosis requires correlation of clinical presentation, electrophysiological findings, elevated muscle enzymes, and distinctive pathological features. The prognosis is generally poor with progressive disability over years.

Usage

Usage note: IBM abbreviation acceptable after first use; distinguish from inflammatory bowel disease IBM.

In Context

  • "The muscle biopsy confirmed inclusion body myositis with characteristic rimmed vacuoles and protein aggregates." — Pathology report
  • "Unlike other inflammatory myopathies, inclusion body myositis shows poor response to corticosteroid therapy." — Treatment review

Also known as

IBM sporadic inclusion body myositis

Don't confuse with

polymyositis dermatomyositis necrotizing myopathy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON